COVID-19 Trials in são paulo, brazil
Conditions / COVID-19 / são paulo, brazil
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
66 total trials for this combination
Showing top 10 of 66 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05605093 | Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) | TERMINATED | PHASE3 |
| NCT05629962 | SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 | COMPLETED | PHASE3 |
| NCT05011513 | Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). | TERMINATED | PHASE2/PHASE3 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | COMPLETED | PHASE2/PHASE3 |
| NCT04955626 | To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. | COMPLETED | PHASE3 |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | COMPLETED | PHASE3 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | COMPLETED | PHASE1/PHASE2 |
| NCT04745351 | Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) | TERMINATED | PHASE3 |
| NCT04834089 | Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases | UNKNOWN | PHASE1/PHASE2 |
| NCT05543616 | A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children | RECRUITING | PHASE2/PHASE3 |